Key Laboratory of Industrial Ecology and Environmental Engineering (Ministry of Education), School of Environmental Science and Technology, Dalian University of Technology, 116024, Dalian, People's Republic of China.
Arch Toxicol. 2011 Jun;85(6):613-21. doi: 10.1007/s00204-010-0613-x. Epub 2010 Nov 3.
The toxicity of perfluorooctane sulfonate (PFOS), a persistent organic compound, is of great concern. Several studies have reported that PFOS decreases circulating thyroid hormone (TH) concentrations. However, the mechanisms involved remain to be determined. Female rats were exposed to (1) vehicle; (2) PFOS (0.2, 1.0, and 3.0 mg/kg); (3) propylthiouracil (PTU, 10 mg/kg); or (4) PTU (10 mg/kg) + PFOS (3.0 mg/kg) by gavage once a day for 5 consecutive days. Parameters including contents of total T4 (TT4) and total T3 (TT3) in both serum and bile, serum concentrations of transthyretin and thyroglobulin, as well as transcripts of transporters involved in hepatic uptake and efflux of T4 were determined in control and PFOS-exposed groups. TT4 and TT3 were also analyzed in PTU and PTU + PFOS groups in order to reflect the different hormone effects between PFOS, PTU, and PFOS + PTU. Results showed that serum TT4 and TT3 decreased, while bile TT4 and TT3 remained stable following PFOS exposure. Exposure to 3.0 mg/kg of PFOS significantly enhanced hepatic organic anion transporter OATP2 mRNA expression (1.43 times of control). Treatment with PFOS increased hepatic expression of multidrug resistance--associated protein MRP2, approximately 1.80 and 1.69 times of control in 1.0 and 3.0 mg/kg groups, respectively. Spearman's correlation coefficients revealed that MRP2 mRNA expression correlated well with serum TT4 level (r = -0.528, P = 0.012). Serum thyroglobulin and transthyretin levels remained stable. Serum TT3, bile TT4, and bile TT3 were significantly different between PFOS and PTU groups. No significant differences of TT4 and TT3 in both serum and bile were observed between PTU and PTU + PFOS (P > 0.05). In conclusion, PFOS increased hepatic expression of OAPT2, which could possibly enhance hepatic uptake and metabolism of T4 in rats. PFOS-induced TT4 deficiency is mainly due to the extrathyroidal metabolism of T4, which is probably different from the classic goitrogen, PTU.
全氟辛烷磺酸 (PFOS) 的毒性是一种持久性有机化合物,引起了广泛关注。有几项研究报告表明,PFOS 会降低循环甲状腺激素 (TH) 浓度。然而,其涉及的机制仍有待确定。雌性大鼠通过灌胃每天一次连续 5 天接受以下处理:(1) 载体;(2) PFOS(0.2、1.0 和 3.0mg/kg);(3) 丙硫氧嘧啶 (PTU,10mg/kg);或(4) PTU(10mg/kg)+PFOS(3.0mg/kg)。在对照组和 PFOS 暴露组中测定了血清和胆汁中总 T4(TT4)和总 T3(TT3)的含量、血清转甲状腺素蛋白和甲状腺球蛋白的浓度以及参与 T4 肝摄取和外排的转运体的转录物。为了反映 PFOS、PTU 和 PFOS+PTU 之间不同的激素作用,还在 PTU 和 PTU+PFOS 组中分析了 TT4 和 TT3。结果表明,PFOS 暴露后血清 TT4 和 TT3 降低,而胆汁 TT4 和 TT3 保持稳定。暴露于 3.0mg/kg 的 PFOS 显著增强了肝脏有机阴离子转运蛋白 OATP2 的 mRNA 表达(对照组的 1.43 倍)。PFOS 处理增加了多药耐药相关蛋白 MRP2 的肝表达,分别为对照组的 1.80 和 1.69 倍,分别为 1.0 和 3.0mg/kg 组。Spearman 相关系数显示,MRP2mRNA 表达与血清 TT4 水平密切相关(r=-0.528,P=0.012)。血清甲状腺球蛋白和转甲状腺素蛋白水平保持稳定。血清 TT3、胆汁 TT4 和胆汁 TT3 在 PFOS 和 PTU 组之间存在显著差异。在 PTU 和 PTU+PFOS 组中,血清和胆汁中的 TT4 和 TT3 均无显著差异(P>0.05)。总之,PFOS 增加了 OAPT2 的肝表达,这可能增强了大鼠 T4 的肝摄取和代谢。PFOS 诱导的 TT4 缺乏主要归因于 T4 的甲状腺外代谢,这可能与经典致甲状腺肿剂 PTU 不同。